Smoking causes cancer, but it could protect against Parkinson’s disease. This has been demonstrated by various epidemiological studies, according to which there exists an inverse relationship between smoking and the probability of developing Parkinson’s disease.
The link is not however 100% clear, as some smokers develop the illness nevertheless. The hypothesis is that there is a genetic predisposition that, in combination with environmental factors, can trigger the disease. Taking this as its starting point, a team from the Mayo Clinic in Rochester, MN (USA) has carried out a study on a sample of 1228 subjects. The team includes Maurizio Facheris, a researcher at the Institute of Genetic Medicine at the European Academy of Bozen/Bolzano (EURAC), previous Research Fellow at the prestigious American clinic and who co-ordinated the study.
The researchers hypothesized that the variation may be due to pharmacogenetic effects and that nicotine might have neuroprotective properties for certain individuals.
“We asked the interviewees to tell us about their relationship with smoking and then compared this data with the presence or absence of variations in the gene CYP2A6, which encodes the enzyme responsible for metabolising nicotine”, says EURAC researcher Maurizio Facheris, neurologist at the Department of Neurology of Bozen/Bolzano Central Hospital and main author of the study.
From an analysis of the data, it emerges that the presence of a particular variant of the gene, when combined with smoking, considerably reduces the risk of contracting Parkinson’s disease. It remains to be clarified whether the protection against the disease is provided by the particular variant of gene CYP2A6 or by the presence of cotinine, the substance into which nicotine is transformed through the action of the gene. “If this second hypothesis is confirmed, producing a cotinine-based drug would be a means to reduce exposure to the disease”, explains Maurizio Facheris.The study opens up interesting scenarios in the field of pharmacogenetics, a discipline that holds that variations in different patients’ response to pharmacological treatment depends on genetic factors. Under this view, analysing the patients’ DNA will allow us to predict their reaction to a particular drug and thus enable the development of personalised medicines.
The study was presented at Toronto on the occasion of the annual convention of the American Academy of Neurology, and was selected as among the top 5% of over 2,000 articles received. It was the first study of its kind to be presented.
Laura Defranceschi | idw
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).
Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
16.02.2018 | Information Technology
16.02.2018 | Health and Medicine
16.02.2018 | Physics and Astronomy